What is suppression of anti-adeno-associated virus capsid T-cells achieving
Document Type
Journal ArticlePublication Date
2014-03-19Keywords
Dependovirus*Genetic Therapy
Genetic Vectors
Humans
Hyperlipoproteinemia Type I
UMCCTS funding
Genetics
Immunoprophylaxis and Therapy
Medical Immunology
Translational Medical Research
Metadata
Show full item recordAbstract
Comment on: Immune responses to intramuscular administration of alipogene tiparvovec (AAV1-LPL(S447X)) in a phase II clinical trial of lipoprotein lipase deficiency gene therapy. [Hum Gene Ther. 2014]Source
Hum Gene Ther. 2014 Mar;25(3):178-9. doi: 10.1089/hum.2014.2506. Link to article on publisher's siteDOI
10.1089/hum.2014.2506Permanent Link to this Item
http://hdl.handle.net/20.500.14038/50484PubMed ID
24628440Related Resources
Link to Article in PubMedae974a485f413a2113503eed53cd6c53
10.1089/hum.2014.2506